Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 7, 2013, Pages 971-979

  Steiner, Johann ^a,b   Gos, Tomasz ^a,c   Bogerts, Bernhard ^a,b   Bielau, Hendrik ^a   Drexhage, Hemmo A ^d   Bernstein, Hans Gert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b CENTER FOR BEHAVIORAL BRAIN SCIENCES   (Germany)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Depression; Immune system; Lymphocytes; Microglia; Monocytes; Mononuclear phagocyte system; Review; Schizophrenia; Suicidality; Suicide

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR RECEPTOR; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KETAMINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLINIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOPSY; CELL ACTIVATION; DEPRESSION; EVIDENCE BASED PRACTICE; HISTOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MICROGLIA; MONOCYTE MACROPHAGE PRECURSOR CELL; MONOCYTOSIS; MONONUCLEAR PHAGOCYTE; NERVE CELL GROWTH; NERVE FUNCTION; NEUROBIOLOGY; NEUROTRANSMISSION; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUICIDAL BEHAVIOR;

BRAIN; CYTOKINES; DEPRESSION; HUMANS; MACROPHAGE ACTIVATION; MICROGLIA; NEUROGENESIS; SCHIZOPHRENIA; SUICIDE; SYNAPTIC TRANSMISSION;

EID: 84889019836     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990099     Document Type: Article

References (110)

1. Hor, K.; Taylor, M. Suicide and schizophrenia: A systematic review of rates and risk factors. J. Psychopharmacol., 2010, 24(4 Suppl), 81-90.
2. Richards, D. Prevalence and clinical course of depression: A review. Clin. Psychol. Rev., 2011, 31(7), 1117-1125.
3. Potvin, S.; Stip, E.; Sepehry, A.A.; Gendron, A.; Bah, R.; Kouassi, E. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol. Psychiatry, 2008, 63, 801-808.
4. Miller, B.J.; Buckley, P.; Seabolt, W.; Mellor, A.; Kirkpatrick, B. Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry, 2011, 70(7), 663-671.
5. Drexhage, R.C.; Knijff, E.M.; Padmos, R.C.; Heul-Nieuwenhuijzen, L.; Beumer, W.; Versnel, M.A.; Drexhage, H.A. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev. Neurother., 2010, 10(1), 59-76.
6. Zorrilla, E.P.; Luborsky, L.; McKay, J.R.; Rosenthal, R.; Houldin, A.; Tax, A.; McCorkle, R.; Seligman, D.A.; Schmidt, K. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav. Immun., 2001, 15(3), 199-226.
7. Steiner, J.; Bogerts, B.; Sarnyai, Z.; Walter, M.; Gos, T.; Bernstein, H.G.; Myint, A.M. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial nmda receptor modulators and impaired blood-brain barrier integrity. World J. Biol. Psychiatry, 2011, in press.
8. Tonelli, L.H.; Stiller, J.; Rujescu, D.; Giegling, I.; Schneider, B.; Maurer, K.; Schnabel, A.; Moller, H.J.; Chen, H.H.; Postolache, T.T. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr. Scand., 2008, 117(3), 198-206.
9. Pandey, G.N.; Rizavi, H.S.; Ren, X.; Fareed, J.; Hoppensteadt, D.A.; Roberts, R.C.; Conley, R.R.; Dwivedi, Y. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J. Psychiatr. Res., 2012, 46(1), 57-63.
10. Lindqvist, D.; Janelidze, S.; Hagell, P.; Erhardt, S.; Samuelsson, M.; Minthon, L.; Hansson, O.; Bjorkqvist, M.; Traskman-Bendz, L.; Brundin, L. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry, 2009, 66(3), 287-292.
11. Lindqvist, D.; Janelidze, S.; Erhardt, S.; Traskman-Bendz, L.; Engstrom, G.; Brundin, L. Csf biomarkers in suicide attempters--a principal component analysis. Acta Psychiatr. Scand., 2011, 124(1), 52-61.
12. Janelidze, S.; Mattei, D.; Westrin, A.; Traskman-Bendz, L.; Brundin, L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav. Immun., 2011, 25(2), 335-339.
13. Steiner, J.; Bielau, H.; Brisch, R.; Danos, P.; Ullrich, O.; Mawrin, C.; Bernstein, H.G.; Bogerts, B. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res., 2008, 42(2), 151-157.
14. Steiner, J.; Mawrin, C.; Ziegeler, A.; Bielau, H.; Ullrich, O.; Bernstein, H.G.; Bogerts, B. Distribution of hla-dr-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol., 2006, 112(3), 305-316.
15. Steiner, J.; Walter, M.; Gos, T.; Guillemin, G.J.; Bernstein, H.G.; Sarnyai, Z.; Mawrin, C.; Brisch, R.; Bielau, H.; Meyer zu Schwabedissen, L.; Bogerts, B.; Myint, A.M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation, 2011, 8, 94.
16. Busse, S.; Busse, M.; Schiltz, K.; Bielau, H.; Gos, T.; Brisch, R.; Mawrin, C.; Schmitt, A.; Jordan, W.; Muller, U.J.; Bernstein, H.G.; Bogerts, B.; Steiner, J. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations? Brain Behav. Immun., 2012, 26(8), 1273-1279.
17. Doorduin, J.; de Vries, E.F.; Willemsen, A.T.; de Groot, J.C.; Dierckx, R.A.; Klein, H.C. Neuroinflammation in schizophrenia-related psychosis: A pet study. J. Nucl. Med., 2009, 50(11), 1801-1807.
18. Beumer, W.; Gibney, S.M.; Drexhage, R.C.; Pont-Lezica, L.; Doorduin, J.; Klein, H.C.; Steiner, J.; Connor, T.J.; Harkin, A.; Versnel, M.A.; Drexhage, H.A. The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. J. Leukoc. Biol., 2012, 92(5), 959-975.
19. Dantzer, R.; O'Connor, J.C.; Freund, G.G.; Johnson, R.W.; Kelley, K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci., 2008, 9(1), 46-56.
20. Myint, A.M.; Leonard, B.E.; Steinbusch, H.W.; Kim, Y.K. Th1, th2, and th3 cytokine alterations in major depression. J. Affect. Disord., 2005, 88(2), 167-173.
21. Kaestner, F.; Hettich, M.; Peters, M.; Sibrowski, W.; Hetzel, G.; Ponath, G.; Arolt, V.; Cassens, U.; Rothermundt, M. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with hpa axis activity. J. Affect. Disord., 2005, 87(2-3), 305-311.
22. Miller, A.H.; Maletic, V.; Raison, C.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol. Psychiatry, 2009, 65(9), 732-741.
23. Padmos, R.C.; Hillegers, M.H.; Knijff, E.M.; Vonk, R.; Bouvy, A.; Staal, F.J.; de Ridder, D.; Kupka, R.W.; Nolen, W.A.; Drexhage, H.A. A discriminating messenger rna signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry, 2008, 65(4), 395-407.
24. Maes, M.; Van der Planken, M.; Stevens, W.J.; Peeters, D.; DeClerck, L.S.; Bridts, C.H.; Schotte, C.; Cosyns, P. Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression. J. Psychiatr. Res., 1992, 26(2), 125-134.
25. Seidel, A.; Arolt, V.; Hunstiger, M.; Rink, L.; Behnisch, A.; Kirchner, H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr. Scand., 1996, 94(3), 198-204.
26. Rothermundt, M.; Arolt, V.; Weitzsch, C.; Eckhoff, D.; Kirchner, H. Immunological dysfunction in schizophrenia: A systematic approach. Neuropsychobiology, 1998, 37(4), 186-193.
27. Carlton, E.; Falcone, T.; Batra, A.; Fazio, V.; Janigro, D. Do systemic inflammation and blood-brain barrier failure play a role in pediatric psychosis? Cleve Clin. J. Med., 2009, 76(Suppl 2), S93a.
28. Nikkilä, H.V.; Müller, K.; Ahokas, A.; Miettinen, K.; Rimon, R.; Andersson, L.C. Accumulation of macrophages in the csf of schizophrenic patients during acute psychotic episodes. Am. J. Psychiatry, 1999, 156(11), 1725-1729.
29. Lee, B.H.; Lee, S.W.; Yoon, D.; Lee, H.J.; Yang, J.C.; Shim, S.H.; Kim, D.H.; Ryu, S.H.; Han, C.; Kim, Y.K. Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology, 2006, 53(3), 127-132.
30. Kim, Y.K.; Paik, J.W.; Lee, S.W.; Yoon, D.; Han, C.; Lee, B.H. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(6), 1091-1096.
31. Ginhoux, F.; Greter, M.; Leboeuf, M.; Nandi, S.; See, P.; Gokhan, S.; Mehler, M.F.; Conway, S.J.; Ng, L.G.; Stanley, E.R.; Samokhvalov, I.M.; Merad, M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 2010, 330(6005), 841-845.
32. Alliot, F.; Godin, I.; Pessac, B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res., 1999, 117(2), 145-152.
33. Kettenmann, H.; Hanisch, U.K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev., 2011, 91(2), 461-553.
34. Schlegelmilch, T.; Henke, K.; Peri, F. Microglia in the developing brain: From immunity to behaviour. Curr. Opin. Neurobiol., 2011, 21(1), 5-10.
35. Tremblay, M.E.; Stevens, B.; Sierra, A.; Wake, H.; Bessis, A.; Nimmerjahn, A. The role of microglia in the healthy brain. J. Neurosci. 2011, 31(45), 16064-16069.
36. Mallat, M.; Marin-Teva, J.L.; Cheret, C. Phagocytosis in the developing cns: More than clearing the corpses. Curr. Opin. Neurobiol., 2005, 15(1), 101-107.
37. Wakselman, S.; Bechade, C.; Roumier, A.; Bernard, D.; Triller, A.; Bessis, A. Developmental neuronal death in hippocampus requires the microglial cd11b integrin and dap12 immunoreceptor. J. Neurosci., 2008, 28(32), 8138-8143.
38. Dalmau, I.; Finsen, B.; Tonder, N.; Zimmer, J.; Gonzalez, B.; Castellano, B. Development of microglia in the prenatal rat hippocampus. J. Comp. Neurol., 1997, 377(1), 70-84.
39. Marin-Teva, J.L.; Dusart, I.; Colin, C.; Gervais, A.; van Rooijen, N.; Mallat, M. Microglia promote the death of developing purkinje cells. Neuron, 2004, 41(4), 535-547.
40. Frade, J.M.; Barde, Y.A. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron, 1998, 20(1), 35-41.
41. Cuadros, M.A.; Garcia-Martin, M.; Martin, C.; Rios, A. Haemopoietic phagocytes in the early differentiating avian retina. J. Anat., 1991, 177, 145-158.
42. Peri, F.; Nusslein-Volhard, C. Live imaging of neuronal degradation by microglia reveals a role for v0-atpase a1 in phagosomal fusion in vivo. Cell, 2008, 133(5), 916-927.
43. Ling, E.A. Some aspects of amoeboid microglia in the corpus callosum and neighbouring regions of neonatal rats. J. Anat., 1976, 121(Pt 1), 29-45.
44. Innocenti, G.M.; Clarke, S.; Koppel, H. Transitory macrophages in the white matter of the developing visual cortex. Ii. Development and relations with axonal pathways. Brain Res., 1983, 313(1), 55-66.
45. Tremblay, M.E.; Lowery, R.L.; Majewska, A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol., 2010, 8(11), e1000527.
46. Stevens, B.; Allen, N.J.; Vazquez, L.E.; Howell, G.R.; Christopherson, K.S.; Nouri, N.; Micheva, K.D.; Mehalow, A.K.; Huberman, A.D.; Stafford, B.; Sher, A.; Litke, A.M.; Lambris, J.D.; Smith, S.J.; John, S.W.; Barres, B.A. The classical complement cascade mediates cns synapse elimination. Cell, 2007, 131(6), 1164-1178.
47. Paolicelli, R.C.; Bolasco, G.; Pagani, F.; Maggi, L.; Scianni, M.; Panzanelli, P.; Giustetto, M.; Ferreira, T.A.; Guiducci, E.; Dumas, L.; Ragozzino, D.; Gross, C.T. Synaptic pruning by microglia is necessary for normal brain development. Science, 2011, 333(6048), 1456-1458.
48. Rogers, J.T.; Morganti, J.M.; Bachstetter, A.D.; Hudson, C.E.; Peters, M.M.; Grimmig, B.A.; Weeber, E.J.; Bickford, P.C.; Gemma, C. Cx3cr1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci., 2011, 31(45), 16241-16250.
49. Maggi, L.; Scianni, M.; Branchi, I.; D'Andrea, I.; Lauro, C.; Limatola, C. Cx(3)cr1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front. Cell. Neurosci., 2011, 5, 22.
50. Chamak, B.; Dobbertin, A.; Mallat, M. Immunohistochemical detection of thrombospondin in microglia in the developing rat brain. Neuroscience, 1995, 69(1), 177-187.
51. Christopherson, K.S.; Ullian, E.M.; Stokes, C.C.; Mullowney, C.E.; Hell, J.W.; Agah, A.; Lawler, J.; Mosher, D.F.; Bornstein, P.; Barres, B.A. Thrombospondins are astrocyte-secreted proteins that promote cns synaptogenesis. Cell, 2005, 120(3), 421-433.
52. Santello, M.; Cali, C.; Bezzi, P. Gliotransmission and the tripartite synapse. Adv. Exp. Med. Biol., 2012, 970, 307-331.
53. Tremblay, M.E.; Majewska, A.K. A role for microglia in synaptic plasticity? Commun. Integr. Biol., 2011, 4(2), 220-222.
54. Nagata, K.; Takei, N.; Nakajima, K.; Saito, H.; Kohsaka, S. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J. Neurosci. Res., 1993, 34(3), 357-363.
55. Chamak, B.; Morandi, V.; Mallat, M. Brain macrophages stimulate neurite growth and regeneration by secreting thrombospondin. J. Neurosci. Res., 1994, 38(2), 221-233.
56. Zhang, S.C.; Fedoroff, S. Neuron-microglia interactions in vitro. Acta Neuropathol., 1996, 91(4), 385-395.
57. Morgan, S.C.; Taylor, D.L.; Pocock, J.M. Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/akt and delta-notch signalling cascades. J. Neurochem., 2004, 90(1), 89-101.
58. Lucin, K.M.; Wyss-Coray, T. Immune activation in brain aging and neurodegeneration: Too much or too little? Neuron, 2009, 64(1), 110-122.
59. Kim, S.U.; de Vellis, J. Microglia in health and disease. J. Neurosci. Res., 2005, 81(3), 302-313.
60. Garden, G.A.; Moller, T. Microglia biology in health and disease. J. Neuroimmune Pharmacol., 2006, 1(2), 127-137.
61. Ben Achour, S.; Pascual, O. Glia: The many ways to modulate synaptic plasticity. Neurochem. Int., 2010, 57(4), 440-445.
62. Sierra, A.; Encinas, J.M.; Deudero, J.J.; Chancey, J.H.; Enikolopov, G.; Overstreet-Wadiche, L.S.; Tsirka, S.E.; Maletic-Savatic, M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell, 2010, 7(4), 483-495.
63. Antony, J.M.; Paquin, A.; Nutt, S.L.; Kaplan, D.R.; Miller, F.D. Endogenous microglia regulate development of embryonic cortical precursor cells. J. Neurosci. Res., 2011, 89(3), 286-298.
64. Ekdahl, C.T.; Kokaia, Z.; Lindvall, O. Brain inflammation and adult neurogenesis: The dual role of microglia. Neuroscience, 2009, 158(3), 1021-1029.
65. Walton, N.M.; Sutter, B.M.; Laywell, E.D.; Levkoff, L.H.; Kearns, S.M.; Marshall, G.P., 2nd; Scheffler, B.; Steindler, D.A. Microglia instruct subventricular zone neurogenesis. Glia, 2006, 54(8), 815-825.
66. Aarum, J.; Sandberg, K.; Haeberlein, S.L.; Persson, M.A. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. USA, 2003, 100(26), 15983-15988.
67. Bechter, K. Updating the mild encephalitis hypothesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, 42, 71-91.
68. Bechter, K.; Reiber, H.; Herzog, S.; Fuchs, D.; Tumani, H.; Maxeiner, H.G. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood-csf barrier dysfunction. J. Psychiatr. Res., 2010, 44(5), 321-330.
69. Bayer, T.A.; Buslei, R.; Havas, L.; Falkai, P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett., 1999, 271(2), 126-128.
70. Radewicz, K.; Garey, L.J.; Gentleman, S.M.; Reynolds, R. Increase in hla-dr immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol., 2000, 59(2), 137-150.
71. Wierzba-Bobrowicz, T.; Lewandowska, E.; Lechowicz, W.; Stepien, T.; Pasennik, E. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol., 2005, 43(2), 81-89.
72. Arnold, S.E.; Trojanowski, J.Q.; Gur, R.E.; Blackwell, P.; Han, L.Y.; Choi, C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry, 1998, 55(3), 225-232.
73. Togo, T.; Akiyama, H.; Kondo, H.; Ikeda, K.; Kato, M.; Iseki, E.; Kosaka, K. Expression of cd40 in the brain of alzheimer's disease and other neurological diseases. Brain Res., 2000, 885(1), 117-121.
74. Falke, E.; Han, L.Y.; Arnold, S.E. Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia. Psychiatry Res., 2000, 93(2), 103-110.
75. Horn, D.I.; Yu, C.; Steiner, J.; Buchmann, J.; Kaufmann, J.; Osoba, A.; Eckert, U.; Zierhut, K.C.; Schiltz, K.; He, H.; Biswal, B.; Bogerts, B.; Walter, M. Glutamatergic and resting-state functional connectivity correlates of severity in major depression -the role of pregenual anterior cingulate cortex and anterior insula. Front. Syst. Neurosci., 2010, 4(33), 10.
76. Walter, M.; Henning, A.; Grimm, S.; Beck, J.; Schulte, R.F.; Dydak, U.; Boeker, H.; Boesinger, P.; Northoff, G. The relationship between aberrant neuronal activation patterns in the pregenual anterior cingulate, altered glutamatergic metabolism and anhedonia in major depression. Arch. Gen. Psychiatry, 2009, 40(1482-1494.
77. Zarate, C.A., Jr.; Singh, J.B.; Carlson, P.J.; Brutsche, N.E.; Ameli, R.; Luckenbaugh, D.A.; Charney, D.S.; Manji, H.K. A randomized trial of an n-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry, 2006, 63(8), 856-864.
78. Rowland, L.M.; Bustillo, J.R.; Mullins, P.G.; Jung, R.E.; Lenroot, R.; Landgraf, E.; Barrow, R.; Yeo, R.; Lauriello, J.; Brooks, W.M. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-t proton mrs study. Am. J. Psychiatry, 2005, 162(2), 394-396.
79. Cosenza-Nashat, M.; Zhao, M.L.; Suh, H.S.; Morgan, J.; Natividad, R.; Morgello, S.; Lee, S.C. Expression of the translocator protein of 18 kda by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol. Appl. Neurobiol., 2009, 35(3), 306-328.
80. Doorduin, J.; de Vries, E.F.; Dierckx, R.A.; Klein, H.C. Pet imaging of the peripheral benzodiazepine receptor: Monitoring disease progression and therapy response in neurodegenerative disorders. Curr. Pharm. Des., 2008, 14(31), 3297-3315.
81. van Berckel, B.N.; Bossong, M.G.; Boellaard, R.; Kloet, R.; Schuitemaker, A.; Caspers, E.; Luurtsema, G.; Windhorst, A.D.; Cahn, W.; Lammertsma, A.A.; Kahn, R.S. Microglia activation in recent-onset schizophrenia: A quantitative (r)-[11c]pk11195 positron emission tomography study. Biol. Psychiatry, 2008, 64(9), 820-822.
82. Bielau, H.; Mawrin, C.; Krell, D.; Agelink, M.W.; Trubner, K.; Davis, R.; Gos, T.; Bogerts, B.; Bernstein, H.G.; Baumann, B. Differences in activation of the dorsal raphe nucleus depending on performance of suicide. Brain Res., 2005, 1039(1-2), 43-52.
83. Jollant, F.; Bellivier, F.; Leboyer, M.; Astruc, B.; Torres, S.; Verdier, R.; Castelnau, D.; Malafosse, A.; Courtet, P. Impaired decision making in suicide attempters. Am. J. Psychiatry, 2005, 162(2), 304-310.
84. van Heeringen, K. The neurobiology of suicide and suicidality. Can. J. Psychiatry, 2003, 48(5), 292-300.
85. Nowak, G.; Ordway, G.A.; Paul, I.A. Alterations in the n-methyl-d-aspartate (nmda) receptor complex in the frontal cortex of suicide victims. Brain Res., 1995, 675(1-2), 157-164.
86. Alonso, R.; Chaudieu, I.; Diorio, J.; Krishnamurthy, A.; Quirion, R.; Boksa, P. Interleukin-2 modulates evoked release of [3h]dopamine in rat cultured mesencephalic cells. J. Neurochem., 1993, 61(4), 1284-1290.
87. Zalcman, S.; Green-Johnson, J.M.; Murray, L.; Nance, D.M.; Dyck, D.; Anisman, H.; Greenberg, A.H. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res., 1994, 643(1-2), 40-49.
88. Labuzek, K.; Kowalski, J.; Gabryel, B.; Herman, Z.S. Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur. Neuropsychopharmacol., 2005, 15(1), 23-30.
89. Baron, D.A.; Hardie, T.; Baron, S.H. Possible association of interleukin-2 treatment with depression and suicide. J. Am. Osteopath. Assoc., 1993, 93(7), 799-800.
90. Walker, L.G.; Walker, M.B.; Heys, S.D.; Lolley, J.; Wesnes, K.; Eremin, O. The psychological and psychiatric effects of ril-2 therapy: A controlled clinical trial. Psychooncology, 1997, 6(4), 290-301.
91. Yamada, K.; Noda, Y.; Nakayama, S.; Komori, Y.; Sugihara, H.; Hasegawa, T.; Nabeshima, T. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol., 1995, 115(5), 852-858.
92. Linden, D.R.; El-Fakahany, E.E. Microglial derived nitric oxide decreases serotonin content in rat basophilic leukemia (rbl-2h3) cells. Eur. J. Pharmacol., 2002, 436(1-2), 53-56.
93. Bernstein, H.G.; Bogerts, B.; Keilhoff, G. The many faces of nitric oxide in schizophrenia. A review. Schizophr. Res., 2005, 78(1), 69-86.
94. Bernstein, H.G.; Heinemann, A.; Krell, D.; Dobrowolny, H.; Bielau, H.; Keilhoff, G.; Bogerts, B. Hypothalamic nitric oxide synthase in affective disorder: Focus on the suprachiasmatic nucleus. Cell Mol. Biol. (Noisy-le-grand), 2005, 51(3), 279-284.
95. Tyring, S.; Gottlieb, A.; Papp, K.; Gordon, K.; Leonardi, C.; Wang, A.; Lalla, D.; Woolley, M.; Jahreis, A.; Zitnik, R.; Cella, D.; Krishnan, R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase iii trial. Lancet, 2006, 367(9504), 29-35.
96. Lai, A.Y.; Todd, K.G. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia, 2006, 53(8), 809-816.
97. Molina-Hernandez, M.; Tellez-Alcantara, N.P.; Perez-Garcia, J.; Olivera-Lopez, J.I.; Jaramillo-Jaimes, M.T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(2), 380-386.
98. Levkovitz, Y.; Mendlovich, S.; Riwkes, S.; Braw, Y.; Levkovitch-Verbin, H.; Gal, G.; Fennig, S.; Treves, I.; Kron, S. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J. Clin. Psychiatry, 2010, 71(2), 138-149.
99. Miyaoka, T.; Yasukawa, R.; Yasuda, H.; Hayashida, M.; Inagaki, T.; Horiguchi, J. Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2007, 31(1), 304-307.
100. Pae, C.U.; Marks, D.M.; Han, C.; Patkar, A.A. Does minocycline have antidepressant effect? Biomed. Pharmacother., 2008, 62(5), 308-311.
101. Liu, Z.; Fan, Y.; Won, S.J.; Neumann, M.; Hu, D.; Zhou, L.; Weinstein, P.R.; Liu, J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke, 2007, 38(1), 146-152.
102. Griffin, M.O.; Fricovsky, E.; Ceballos, G.; Villarreal, F. Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am. J. Physiol. Cell Physiol., 2010, 299(3), C539-548.
103. Akhondzadeh, S.; Tabatabaee, M.; Amini, H.; Ahmadi Abhari, S.A.; Abbasi, S.H.; Behnam, B. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr. Res., 2007, 90(1-3), 179-185.
104. Müller, N. Cox-2 inhibitors as antidepressants and antipsychotics: Clinical evidence. Curr. Opin. Investig. Drugs, 2010, 11(1), 31-42.
105. Myint, A.M.; Kim, Y.K.; Verkerk, R.; Scharpe, S.; Steinbusch, H.; Leonard, B. Kynurenine pathway in major depression: Evidence of impaired neuroprotection. J. Affect. Disord., 2007, 98(1-2), 143-151.
106. Raison, C.L.; Dantzer, R.; Kelley, K.W.; Lawson, M.A.; Woolwine, B.J.; Vogt, G.; Spivey, J.R.; Saito, K.; Miller, A.H. Csf concentrations of brain tryptophan and kynurenines during immune stimulation with ifn-alpha: Relationship to cns immune responses and depression. Mol. Psychiatry, 2010, 15(4), 393-403.
107. Price, R.B.; Nock, M.K.; Charney, D.S.; Mathew, S.J. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol. Psychiatry, 2009, 66(5), 522-526.
108. Diazgranados, N.; Ibrahim, L.; Brutsche, N.E.; Newberg, A.; Kronstein, P.; Khalife, S.; Kammerer, W.A.; Quezado, Z.; Luckenbaugh, D.A.; Salvadore, G.; Machado-Vieira, R.; Manji, H.K.; Zarate, C.A., Jr. A randomized add-on trial of an n-methyl-d-aspartate antagonist in treatment-resistant bipolar depression. Arch. Gen. Psychiatry, 2010, 67(8), 793-802.
109. Zarate, C.A., Jr.; Brutsche, N.E.; Ibrahim, L.; Franco-Chaves, J.; Diazgranados, N.; Cravchik, A.; Selter, J.; Marquardt, C.A.; Liberty, V.; Luckenbaugh, D.A. Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial. Biol. Psychiatry, 2012, 71(11), 939-946.
110. Erhardt, S.; Lim, C.K.; Linderholm, K.R.; Janelidze, S.; Lindqvist, D.; Samuelsson, M.; Lundberg, K.; Postolache, T.T.; Traskman-Bendz, L.; Guillemin, G.J.; Brundin, L. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology, 2013, 38(5), 743-752.